RT Journal Article
SR Electronic
T1 Metabolic control of NLRP3 inflammasome by itaconation
JF Science Translational Medicine
FD American Association for the Advancement of Science
SP eabe1714
DO 10.1126/scitranslmed.abe1714
VO 12
IS 561
A1 Van den Bossche, Jan
YR 2020
UL http://stm.sciencemag.org/content/12/561/eabe1714.abstract
AB The Krebs cycle–derived immunometabolite itaconate constrains NLRP3 inflammasome activation and IL-1β release.